196 related articles for article (PubMed ID: 34837099)
1. Continuous use of metformin in patients receiving contrast medium: what is the evidence? A systematic review and meta-analysis.
Kao TW; Lee KH; Chan WP; Fan KC; Liu CW; Huang YC
Eur Radiol; 2022 May; 32(5):3045-3055. PubMed ID: 34837099
[TBL] [Abstract][Full Text] [Related]
2. Hospitalization for Lactic Acidosis Among Patients With Reduced Kidney Function Treated With Metformin or Sulfonylureas.
Chu PY; Hackstadt AJ; Chipman J; Griffin MR; Hung AM; Greevy RA; Grijalva CG; Elasy T; Roumie CL
Diabetes Care; 2020 Jul; 43(7):1462-1470. PubMed ID: 32327421
[TBL] [Abstract][Full Text] [Related]
3. Acute kidney injury, plasma lactate concentrations and lactic acidosis in metformin users: A GoDarts study.
Connelly PJ; Lonergan M; Soto-Pedre E; Donnelly L; Zhou K; Pearson ER
Diabetes Obes Metab; 2017 Nov; 19(11):1579-1586. PubMed ID: 28432751
[TBL] [Abstract][Full Text] [Related]
4. Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? No, We Should Never Again Compromise Safety!
Kalantar-Zadeh K; Kovesdy CP
Diabetes Care; 2016 Jul; 39(7):1281-6. PubMed ID: 27330129
[TBL] [Abstract][Full Text] [Related]
5. Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? Yes, They Should Be Relaxed! What's the Fuss?
Bakris GL; Molitch ME
Diabetes Care; 2016 Jul; 39(7):1287-91. PubMed ID: 27330130
[TBL] [Abstract][Full Text] [Related]
6. Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin.
Goergen SK; Rumbold G; Compton G; Harris C
Radiology; 2010 Jan; 254(1):261-9. PubMed ID: 20032157
[TBL] [Abstract][Full Text] [Related]
7. Metformin Can Be Safely Used in Patients Exposed to Contrast Media: A Systematic Review and Meta-Analysis.
Qiao H; Li Y; Xu B; Lu Z; Zhang J; Meng D; He S; Huang J
Cardiology; 2022; 147(5-6):469-478. PubMed ID: 36202076
[TBL] [Abstract][Full Text] [Related]
8. Association of Metformin Use With Risk of Lactic Acidosis Across the Range of Kidney Function: A Community-Based Cohort Study.
Lazarus B; Wu A; Shin JI; Sang Y; Alexander GC; Secora A; Inker LA; Coresh J; Chang AR; Grams ME
JAMA Intern Med; 2018 Jul; 178(7):903-910. PubMed ID: 29868840
[TBL] [Abstract][Full Text] [Related]
9. Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients : Recommendations for updated ESUR Contrast Medium Safety Committee guidelines.
van der Molen AJ; Reimer P; Dekkers IA; Bongartz G; Bellin MF; Bertolotto M; Clement O; Heinz-Peer G; Stacul F; Webb JAW; Thomsen HS
Eur Radiol; 2018 Jul; 28(7):2856-2869. PubMed ID: 29417249
[TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis of lactic acidosis-related parameters upon and after metformin discontinuation in patients with diabetes and chronic kidney disease.
Sipahi S; Solak Y; Acikgoz SB; Genc AB; Yildirim M; Yilmaz U; Nalbant A; Tamer A
Int Urol Nephrol; 2016 Aug; 48(8):1305-1312. PubMed ID: 27102431
[TBL] [Abstract][Full Text] [Related]
11. AKI with serious state of acidosis in diabetic patients treated with metformin.
Girasole F; Piccolo G; Timpanelli R; Calanna M; Piazza F; Vecchio S
G Ital Nefrol; 2013; 30(5):. PubMed ID: 24402626
[TBL] [Abstract][Full Text] [Related]
12. Metformin-related lactic acidosis with acute kidney injury: results of a French observational multicenter study.
Corchia A; Wynckel A; Journet J; Moussi Frances J; Skandrani N; Lautrette A; Zafrani L; Lewandowski E; Reboul P; Vrigneaud L; Djerada Z; Rieu P
Clin Toxicol (Phila); 2020 May; 58(5):375-382. PubMed ID: 31387415
[No Abstract] [Full Text] [Related]
13. Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study.
Bell S; Farran B; McGurnaghan S; McCrimmon RJ; Leese GP; Petrie JR; McKeigue P; Sattar N; Wild S; McKnight J; Lindsay R; Colhoun HM; Looker H
BMC Nephrol; 2017 May; 18(1):163. PubMed ID: 28526011
[TBL] [Abstract][Full Text] [Related]
14. Metformin-associated lactic acidosis following acute kidney injury. Efficacious treatment with continuous renal replacement therapy.
Dichtwald S; Weinbroum AA; Sorkine P; Ekstein MP; Dahan E
Diabet Med; 2012 Feb; 29(2):245-50. PubMed ID: 21977945
[TBL] [Abstract][Full Text] [Related]
15. Metformin use and risk of lactic acidosis in people with diabetes with and without renal impairment: a cohort study in Denmark and the UK.
Li L; Jick S; Gopalakrishnan C; Heide-Jørgensen U; Nørrelund H; Sørensen HT; Christiansen CF; Ehrenstein V
Diabet Med; 2017 Apr; 34(4):485-489. PubMed ID: 27504911
[TBL] [Abstract][Full Text] [Related]
16. Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study.
Eppenga WL; Lalmohamed A; Geerts AF; Derijks HJ; Wensing M; Egberts A; De Smet PA; de Vries F
Diabetes Care; 2014 Aug; 37(8):2218-24. PubMed ID: 24842984
[TBL] [Abstract][Full Text] [Related]
17. Preventing contrast medium-induced acute kidney injury : Side-by-side comparison of Swedish-ESUR guidelines.
Nyman U; Ahlkvist J; Aspelin P; Brismar T; Frid A; Hellström M; Liss P; Sterner G; Leander P;
Eur Radiol; 2018 Dec; 28(12):5384-5395. PubMed ID: 30132106
[TBL] [Abstract][Full Text] [Related]
18. Safety and effectiveness of metformin in patients with reduced renal function: A systematic review.
Orloff J; Min JY; Mushlin A; Flory J
Diabetes Obes Metab; 2021 Sep; 23(9):2035-2047. PubMed ID: 34009711
[TBL] [Abstract][Full Text] [Related]
19. Metformin: time to review its role and safety in chronic kidney disease.
Tanner C; Wang G; Liu N; Andrikopoulos S; Zajac JD; Ekinci EI
Med J Aust; 2019 Jul; 211(1):37-42. PubMed ID: 31187887
[TBL] [Abstract][Full Text] [Related]
20. Adverse event notifications implicating metformin with lactic acidosis in Australia.
Huang W; Castelino RL; Peterson GM
J Diabetes Complications; 2015; 29(8):1261-5. PubMed ID: 26104729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
